A Phase I Trial and in vitro Studies Combining ABT-751 with Carboplatin in Previously Treated Non-Small Cell Lung Cancer Patients

Publisher： Karger

E-ISSN： 1421-9794|58|4|321-329

ISSN： 0009-3157

Source： Chemotherapy, Vol.58, Iss.4, 2012-11, pp. : 321-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study Directed by a Clinical Pathway for Carboplatin and Weekly Paclitaxel in Previously Untreated Patients with Unresectable Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 56, Iss. 1, 2010-02 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

A Randomized Phase II Trial of Gemcitabine plus Carboplatin: Biweekly versus Standard Schedules in Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 5, 2014-05 ,pp. : 346-353

Karger

Access to resources Recommend Favorite

A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-04 ,pp. : 8-13

Karger

Access to resources Recommend Favorite

A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 61, Iss. 3, 2016-01 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 4, 2012-08 ,pp. : 257-263

Karger

Access to resources Recommend Favorite